Jeff Goater is the founder of Surface Oncology. Surface Oncology has raised $35M in total funding. Latest round: IPO. Based in Cambridge, Massachusetts.
Jeff Goater is a biotech executive with over 20 years of experience, including expertise in gene therapy. He has served as CEO of Surface Oncology, where he led the company through its initial public offering and secured strategic collaborations. Currently, he is a Venture Partner at The Column Group and Interim CEO of Atavistik Bio, and also serves as Chair of the Board of Directors for AviadoBio.
Full founder directory · Investor directory · Company funding database · Fundraising library